Cargando…

The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes

BACKGROUND: Inflammation appears to have a critical role in carcinogenesis tumor growth according to emerging research. The platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and plasma C-reactive protein (CRP) are considered to reflect the systemic inflammatory response and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Cong, Gong, Shengping, Niu, Tingting, Li, Tongyu, Wu, An, Zheng, Xiaojiao, Yang, Shujun, Ouyang, Guifang, Mu, Qitian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086900/ https://www.ncbi.nlm.nih.gov/pubmed/35558519 http://dx.doi.org/10.3389/fonc.2022.877981

Ejemplares similares

Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome
por: Shi, Cong, et al.
Publicado: (2022)

Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis
por: Li, Bixia, et al.
Publicado: (2019)

Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes
por: Shi, Cong, et al.
Publicado: (2022)

Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia
por: Li, Tongyu, et al.
Publicado: (2023)

The Differential Expression of CD47 may be Related to the Pathogenesis From Myelodysplastic Syndromes to Acute Myeloid Leukemia
por: Yan, Xiao, et al.
Publicado: (2022)

MLL-SEPT5 Fusion Transcript in Myelodysplastic Syndrome Patient With t(11;22)(q23;q11)
por: Zou, Duobing, et al.
Publicado: (2021)

Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome
por: Chen, Ying, et al.
Publicado: (2023)

Hsa_circ_0012152 and Hsa_circ_0001857 Accurately Discriminate Acute Lymphoblastic Leukemia From Acute Myeloid Leukemia
por: Guo, Shanshan, et al.
Publicado: (2020)

Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes
por: Wu, An, et al.
Publicado: (2021)

Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung
por: Chen, Zhiyong, et al.
Publicado: (2022)

Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation
por: Wang, Hong, et al.
Publicado: (2022)

Development of anoikis-related genes signature to predict the prognosis in gastric cancer patients
por: Cao, Jie, et al.
Publicado: (2023)

Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features
por: Sheng, Lixia, et al.
Publicado: (2023)

Use of Pretherapy Core Biopsy in the Diagnosis of Pediatric Renal Tumors
por: Kurian, Jujju Jacob, et al.
Publicado: (2018)

A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation
por: Ma, Liya, et al.
Publicado: (2022)

Prognostic Value of Clinical Biochemistry-Based Indexes in Nasopharyngeal Carcinoma
por: Zeng, Xiaojiao, et al.
Publicado: (2020)

Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome
por: Wang, Ming-Jing, et al.
Publicado: (2021)

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes
por: Chen, Qiuni, et al.
Publicado: (2022)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
por: Taprogge, Jan, et al.
Publicado: (2023)

Metastatic HPV‐related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment
por: Perri, Francesco, et al.
Publicado: (2017)

Investigation of the Suitability of a Commercial Radiation Sensor for Pretherapy Dosimetry of Radioiodine Treatment Patients
por: O’Callaghan, Janet, et al.
Publicado: (2022)

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma
por: Voorhees, Timothy J., et al.
Publicado: (2022)

Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?
por: Book, Reut, et al.
Publicado: (2023)

Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study
por: Wang, Yixi, et al.
Publicado: (2019)

Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia
por: Cheng, Zhiheng, et al.
Publicado: (2021)

ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
por: Maldarelli, Frank, et al.
Publicado: (2007)

MiR-181a functions as an oncogene by regulating CCND1 in multiple myeloma
por: Yan, Xiao, et al.
Publicado: (2020)

The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation
por: Hou, Chang, et al.
Publicado: (2021)

Editorial: Risk-stratification in myelodysplastic syndromes
por: Breccia, Massimo, et al.
Publicado: (2022)

Unusual expansion of CD3+CD56+ natural killer T-like cells in peripheral blood after anticytokine treatment for graft-versus-host disease: A case report
por: Sheng, Lixia, et al.
Publicado: (2018)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
por: Wan, Ziqi, et al.
Publicado: (2020)

Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer
por: Hu, Zhe-Yu, et al.
Publicado: (2022)

Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis
por: Tan, Xiangyu, et al.
Publicado: (2021)

Increased Circulating of CD54(high)CD181(low) Neutrophils in Myelodysplastic Syndrome
por: Yang, Liyan, et al.
Publicado: (2021)

Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
por: Tong, Tongyu, et al.
Publicado: (2020)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
por: Aanei, Carmen Mariana, et al.
Publicado: (2016)

BMT for Myelodysplastic Syndrome: When and Where and How
por: Jain, Akriti G., et al.
Publicado: (2022)

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_njl185f6avu0ludtjnh2e9k0so